Ez Aldeen Esawi

Ez Aldeen Esawi

Higher Degree by Research Candidate

South Australian Immunogenomics Cancer Institute

Faculty of Health and Medical Sciences


  • Journals

    Year Citation
    2023 Nsairat, H., Alshaer, W., Odeh, F., Esawi, E., Khater, D., Bawab, A. A., . . . Mubarak, M. S. (2023). Recent advances in using liposomes for delivery of nucleic acid-based therapeutics. OpenNano, 11, 100132.
    DOI
    2023 Alshaer, W., Nsairat, H., Lafi, Z., Hourani, O. M., Al-Kadash, A., Esawi, E., & Alkilany, A. M. (2023). Quality by Design Approach in Liposomal Formulations: Robust Product Development. Molecules, 28(1), 19 pages.
    DOI Scopus9 WoS4 Europe PMC2
    2023 Abuarqoub, D., Mahmoud, N., Alshaer, W., Mohammad, M., Ibrahim, A. A., Al-Mrahleh, M., . . . Awidi, A. (2023). Biological Performance of Primary Dental Pulp Stem Cells Treated with Gold Nanoparticles. Biomedicines, 11(9), 1-15.
    DOI
    2023 Niemi, M. E. K., Karjalainen, J., Liao, R. G., Neale, B. M., Daly, M., Ganna, A., . . . Sedaghati-Khayat, B. (2023). Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x). Nature, 621(7977), E7-E26.
    DOI Scopus12 WoS4 Europe PMC7
    2022 Al-Azzawi, H., Alshaer, W., Esawi, E., Lafi, Z., Abuarqoub, D., Zaza, R., . . . Awidi, A. (2022). Multifunctional nanoparticles recruiting hyaluronic acid ligand and polyplexes containing low molecular weight protamine and ATP-Sensitive DNA motif for doxorubicin delivery. Journal of Drug Delivery Science and Technology, 69, 11 pages.
    DOI Scopus1
    2022 The COVID-19 Host Genetics Initiative., & Ganna, A. (2022). A second update on mapping the human genetic architecture of COVID-19.
    DOI
    2021 Sweidan, N., Esawi, E., Ismail, M., & Alshaer, W. (2021). Anticancer Cardenolides from the aerial parts of Calortopis procera. Zeitschrift fur Naturforschung - Section C Journal of Biosciences, 76(5), 243-250.
    DOI Scopus2 WoS1 Europe PMC1
    2021 Mahmoud, I. S., Hatmal, M. M., Abuarqoub, D., Esawi, E., Zalloum, H., Wehaibi, S., . . . Alshaer, W. (2021). 1,4-Naphthoquinone Is a Potent Inhibitor of IRAK1 Kinases and the Production of Inflammatory Cytokines in THP-1 Differentiated Macrophages. ACS OMEGA, 6(39), 25299-25310.
    DOI WoS5 Europe PMC10
    2021 Esawi, E., Alshaer, W., Mahmoud, I. S., Alqudah, D. A., Azab, B., & Awidi, A. (2021). Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells. International Journal of Molecular Sciences, 22(23), 12940.
    DOI WoS3 Europe PMC3
    2020 Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., . . . Ismail, S. I. (2020). Aptamers Chemistry: Chemical Modifications and Conjugation Strategies. MOLECULES, 25(1), 51 pages.
    DOI WoS154 Europe PMC101
  • Book Chapters

    Year Citation
    2023 Esawi, E., Nsairat, H., Mahmoud, I. S., Lafi, Z., Al-Kadash, A., Al-Ragheb, B. A., . . . Alhaer, W. (2023). Clinical use and future perspective of aptamers. In Aptamers Engineered Nanocarriers for Cancer Therapy (pp. 481-520). Elsevier.
    DOI
    2022 Nsairat, H., Alshaer, W., Mahmoud, I. S., Ismail, M. A., Esawi, E., Alsotari, S., & Ismail, S. I. (2022). Aptamers in Theranostic Bionanomaterials. In Bionanotechnology: Next-Generation Therapeutic Tools (pp. 130-158). BENTHAM SCIENCE PUBLISHERS.
    DOI

Connect With Me
External Profiles